Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...
Noida: Doctors at Noida's Post Graduate Institute of Child Health have detected a rare Coenzyme Q10 deficiency in a ...
When we can play any part in supporting other families, it’s a tragic gift that allows us to continue to parent Havi.” For ...
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...
A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...
Two-thirds of animal and plant populations are declining in genetic diversity, which makes it harder to adapt to environmental changes, according to research published Wednesday.
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approval On track to dose first patient in Phase 3 trial in second half of 2025 LONDON, Feb. 03, 2025 (GLOBE NEWSWIRE) ...
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...